{"count":2858,"next":"https://grand.networkmedicine.org/api/v1/drugapi/?format=json&page=42","previous":"https://grand.networkmedicine.org/api/v1/drugapi/?format=json&page=40","results":[{"number":2001,"drug":"motesanib","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/motesanib.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/motesanib","samples":215,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/motesanib_drug\">motesanib</a>","nsamples":215.0,"avgtftar":16.0093,"avggenetar":327.0556,"moa":"KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor","indication":"-"},{"number":2002,"drug":"moxidectin","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/moxidectin.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/moxidectin","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/moxidectin_drug\">moxidectin</a>","nsamples":42.0,"avgtftar":27.0465,"avggenetar":769.5116,"moa":"chloride channel antagonist","indication":"gastrointestinal parasites"},{"number":2003,"drug":"moxifloxacin","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/moxifloxacin.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/moxifloxacin","samples":75,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/moxifloxacin_drug\">moxifloxacin</a>","nsamples":75.0,"avgtftar":18.7632,"avggenetar":382.5,"moa":"bacterial DNA gyrase inhibitor","indication":"sinusitis|bronchitis|pneumonia|skin infections|intra-abdominal infections"},{"number":2004,"drug":"moxisylyte","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/moxisylyte.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/moxisylyte","samples":61,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/moxisylyte_drug\">moxisylyte</a>","nsamples":61.0,"avgtftar":17.2581,"avggenetar":540.3226,"moa":"adrenergic receptor antagonist","indication":"-"},{"number":2005,"drug":"moxonidine","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/moxonidine.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/moxonidine","samples":76,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/moxonidine_drug\">moxonidine</a>","nsamples":76.0,"avgtftar":20.2338,"avggenetar":369.6883,"moa":"imidazoline receptor agonist","indication":"hypertension"},{"number":2006,"drug":"mozavaptan","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/mozavaptan.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/mozavaptan","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/mozavaptan_drug\">mozavaptan</a>","nsamples":42.0,"avgtftar":11.6279,"avggenetar":256.907,"moa":"vasopressin receptor antagonist","indication":"hyponatremia"},{"number":2007,"drug":"mubritinib","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/mubritinib.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/mubritinib","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/mubritinib_drug\">mubritinib</a>","nsamples":42.0,"avgtftar":11.1628,"avggenetar":472.2326,"moa":"protein tyrosine kinase inhibitor","indication":"-"},{"number":2008,"drug":"mupirocin","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/mupirocin.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/mupirocin","samples":11,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/mupirocin_drug\">mupirocin</a>","nsamples":11.0,"avgtftar":37.5,"avggenetar":237.4167,"moa":"isoleucyl-tRNA synthetase inhibitor","indication":"impetigo"},{"number":2009,"drug":"mycophenolate-mofetil","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/mycophenolate-mofetil.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/mycophenolate-mofetil","samples":61,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/mycophenolate-mofetil_drug\">mycophenolate-mofetil</a>","nsamples":61.0,"avgtftar":7.3871,"avggenetar":161.3548,"moa":"dehydrogenase inhibitor|inositol monophosphatase inhibitor","indication":"organ rejection"},{"number":2010,"drug":"mycophenolic-acid","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/mycophenolic-acid.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/mycophenolic-acid","samples":89,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/mycophenolic-acid_drug\">mycophenolic-acid</a>","nsamples":89.0,"avgtftar":13.8556,"avggenetar":224.1889,"moa":"dehydrogenase inhibitor|inositol monophosphatase inhibitor","indication":"organ rejection"},{"number":2011,"drug":"myricetin","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/myricetin.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/myricetin","samples":35,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/myricetin_drug\">myricetin</a>","nsamples":35.0,"avgtftar":15.9444,"avggenetar":274.0556,"moa":"androgen receptor agonist|cytochrome P450 inhibitor","indication":"-"},{"number":2012,"drug":"nTZDpa","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nTZDpa.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nTZDpa","samples":19,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nTZDpa_drug\">nTZDpa</a>","nsamples":19.0,"avgtftar":0.55,"avggenetar":197.5,"moa":"PPAR receptor agonist","indication":"-"},{"number":2013,"drug":"nabumetone","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nabumetone.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nabumetone","samples":19,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nabumetone_drug\">nabumetone</a>","nsamples":19.0,"avgtftar":3.2,"avggenetar":91.35,"moa":"cyclooxygenase inhibitor","indication":"rheumatoid arthritis|osteoarthritis"},{"number":2014,"drug":"nadide","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nadide.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nadide","samples":4,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nadide_drug\">nadide</a>","nsamples":4.0,"avgtftar":0.0,"avggenetar":18.0,"moa":"free radical scavenger","indication":"-"},{"number":2015,"drug":"nadifloxacin","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nadifloxacin.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nadifloxacin","samples":4,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nadifloxacin_drug\">nadifloxacin</a>","nsamples":4.0,"avgtftar":0.8,"avggenetar":188.0,"moa":"bacterial DNA gyrase inhibitor","indication":"acne vulgaris (AV)|skin infections"},{"number":2016,"drug":"nadolol","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nadolol.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nadolol","samples":57,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nadolol_drug\">nadolol</a>","nsamples":57.0,"avgtftar":22.4138,"avggenetar":456.4655,"moa":"adrenergic receptor antagonist","indication":"angina pectoris|hypertension"},{"number":2017,"drug":"nafadotride","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nafadotride.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nafadotride","samples":32,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nafadotride_drug\">nafadotride</a>","nsamples":32.0,"avgtftar":27.3333,"avggenetar":497.6667,"moa":"dopamine receptor antagonist","indication":"-"},{"number":2018,"drug":"nafamostat","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nafamostat.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nafamostat","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nafamostat_drug\">nafamostat</a>","nsamples":42.0,"avgtftar":9.3488,"avggenetar":210.6977,"moa":"serine protease inhibitor","indication":"anticoagulent"},{"number":2019,"drug":"nafcillin","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nafcillin.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nafcillin","samples":30,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nafcillin_drug\">nafcillin</a>","nsamples":30.0,"avgtftar":35.5484,"avggenetar":491.1935,"moa":"bacterial cell wall synthesis inhibitor","indication":"gram-positive bacterial infections"},{"number":2020,"drug":"naftidrofuryl","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naftidrofuryl.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naftidrofuryl","samples":68,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naftidrofuryl_drug\">naftidrofuryl</a>","nsamples":68.0,"avgtftar":34.942,"avggenetar":569.7101,"moa":"adrenergic receptor antagonist","indication":"claudication"},{"number":2021,"drug":"naftifine","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naftifine.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naftifine","samples":65,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naftifine_drug\">naftifine</a>","nsamples":65.0,"avgtftar":29.4848,"avggenetar":530.3333,"moa":"fungal squalene epoxidase inhibitor","indication":"tinea pedis|tinea cruris|tinea corporis"},{"number":2022,"drug":"naftopidil","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naftopidil.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naftopidil","samples":57,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naftopidil_drug\">naftopidil</a>","nsamples":57.0,"avgtftar":2.2069,"avggenetar":112.569,"moa":"adrenergic receptor antagonist","indication":"benign prostatic hyperplasia (BPH)"},{"number":2023,"drug":"nalbuphine","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nalbuphine.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nalbuphine","samples":90,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nalbuphine_drug\">nalbuphine</a>","nsamples":90.0,"avgtftar":5.6813,"avggenetar":207.7582,"moa":"opioid receptor agonist|opioid receptor antagonist","indication":"pain relief"},{"number":2024,"drug":"nalidixic-acid","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nalidixic-acid.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nalidixic-acid","samples":4,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nalidixic-acid_drug\">nalidixic-acid</a>","nsamples":4.0,"avgtftar":3.4,"avggenetar":853.2,"moa":"bacterial DNA gyrase inhibitor","indication":"urinary tract infections"},{"number":2025,"drug":"naloxone","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naloxone.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naloxone","samples":82,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naloxone_drug\">naloxone</a>","nsamples":82.0,"avgtftar":35.7108,"avggenetar":661.9398,"moa":"opioid receptor antagonist","indication":"respiratory depression"},{"number":2026,"drug":"naltrexone","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naltrexone.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naltrexone","samples":81,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naltrexone_drug\">naltrexone</a>","nsamples":81.0,"avgtftar":10.5244,"avggenetar":269.6341,"moa":"opioid receptor antagonist","indication":"abstinence from alcohol"},{"number":2027,"drug":"naltriben","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naltriben.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naltriben","samples":19,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naltriben_drug\">naltriben</a>","nsamples":19.0,"avgtftar":40.3,"avggenetar":417.1,"moa":"opioid receptor antagonist","indication":"-"},{"number":2028,"drug":"naltrindole","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naltrindole.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naltrindole","samples":30,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naltrindole_drug\">naltrindole</a>","nsamples":30.0,"avgtftar":25.9355,"avggenetar":700.3871,"moa":"opioid receptor antagonist","indication":"-"},{"number":2029,"drug":"nandrolone","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nandrolone.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nandrolone","samples":53,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nandrolone_drug\">nandrolone</a>","nsamples":53.0,"avgtftar":57.2778,"avggenetar":1276.9815,"moa":"imidazoline receptor agonist","indication":"anemia"},{"number":2030,"drug":"naphazoline","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naphazoline.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naphazoline","samples":64,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naphazoline_drug\">naphazoline</a>","nsamples":64.0,"avgtftar":18.0769,"avggenetar":357.8,"moa":"adrenergic receptor agonist","indication":"eye irritation"},{"number":2031,"drug":"naproxen","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naproxen.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naproxen","samples":81,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naproxen_drug\">naproxen</a>","nsamples":81.0,"avgtftar":13.439,"avggenetar":326.1707,"moa":"cyclooxygenase inhibitor","indication":"pain relief|rheumatoid arthritis|headache|toothache|backache|muscle pain|common cold|fever"},{"number":2032,"drug":"naringenin","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naringenin.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naringenin","samples":65,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naringenin_drug\">naringenin</a>","nsamples":65.0,"avgtftar":31.7727,"avggenetar":580.303,"moa":"aromatase inhibitor|TRPV antagonist","indication":"-"},{"number":2033,"drug":"naringin","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/naringin.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/naringin","samples":15,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/naringin_drug\">naringin</a>","nsamples":15.0,"avgtftar":12.5,"avggenetar":277.25,"moa":"cytochrome P450 inhibitor","indication":"-"},{"number":2034,"drug":"narlaprevir","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/narlaprevir.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/narlaprevir","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/narlaprevir_drug\">narlaprevir</a>","nsamples":42.0,"avgtftar":16.093,"avggenetar":400.8605,"moa":"HCV inhibitor","indication":"-"},{"number":2035,"drug":"nateglinide","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nateglinide.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nateglinide","samples":72,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nateglinide_drug\">nateglinide</a>","nsamples":72.0,"avgtftar":22.8904,"avggenetar":478.7123,"moa":"insulin secretagogue","indication":"diabetes mellitus"},{"number":2036,"drug":"navitoclax","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/navitoclax.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/navitoclax","samples":101,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/navitoclax_drug\">navitoclax</a>","nsamples":101.0,"avgtftar":11.2353,"avggenetar":370.8235,"moa":"BCL inhibitor","indication":"-"},{"number":2037,"drug":"nebivolol","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nebivolol.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nebivolol","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nebivolol_drug\">nebivolol</a>","nsamples":42.0,"avgtftar":1.814,"avggenetar":186.0,"moa":"adrenergic receptor antagonist","indication":"hypertension"},{"number":2038,"drug":"necrostatin-1","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/necrostatin-1.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/necrostatin-1","samples":78,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/necrostatin-1_drug\">necrostatin-1</a>","nsamples":78.0,"avgtftar":40.7595,"avggenetar":722.9747,"moa":"RIPK inhibitor","indication":"-"},{"number":2039,"drug":"nefazodone","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nefazodone.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nefazodone","samples":72,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nefazodone_drug\">nefazodone</a>","nsamples":72.0,"avgtftar":29.5342,"avggenetar":551.3151,"moa":"adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor","indication":"-"},{"number":2040,"drug":"nefiracetam","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nefiracetam.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nefiracetam","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nefiracetam_drug\">nefiracetam</a>","nsamples":42.0,"avgtftar":29.4884,"avggenetar":566.0233,"moa":"acetylcholine receptor agonist|benzodiazepine receptor agonist","indication":"-"},{"number":2041,"drug":"nefopam","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nefopam.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nefopam","samples":64,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nefopam_drug\">nefopam</a>","nsamples":64.0,"avgtftar":23.0,"avggenetar":435.6615,"moa":"cyclooxygenase inhibitor","indication":"pain relief"},{"number":2042,"drug":"nelarabine","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nelarabine.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nelarabine","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nelarabine_drug\">nelarabine</a>","nsamples":42.0,"avgtftar":0.9302,"avggenetar":148.3256,"moa":"DNA synthesis inhibitor|T cell inhibitor","indication":"acute lymphoblastic leukemia (ALL)"},{"number":2043,"drug":"nelfinavir","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nelfinavir.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nelfinavir","samples":29,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nelfinavir_drug\">nelfinavir</a>","nsamples":29.0,"avgtftar":34.0,"avggenetar":574.3,"moa":"HIV protease inhibitor","indication":"human immunodeficiency virus (HIV-1)"},{"number":2044,"drug":"nemonapride","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nemonapride.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nemonapride","samples":73,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nemonapride_drug\">nemonapride</a>","nsamples":73.0,"avgtftar":24.0135,"avggenetar":587.3784,"moa":"dopamine receptor antagonist","indication":"schizophrenia"},{"number":2045,"drug":"neomycin","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/neomycin.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/neomycin","samples":3,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/neomycin_drug\">neomycin</a>","nsamples":3.0,"avgtftar":0.0,"avggenetar":18.5,"moa":"bacterial 30S ribosomal subunit inhibitor","indication":"first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections"},{"number":2046,"drug":"neostigmine","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/neostigmine.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/neostigmine","samples":46,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/neostigmine_drug\">neostigmine</a>","nsamples":46.0,"avgtftar":0.617,"avggenetar":237.7872,"moa":"acetylcholinesterase inhibitor","indication":"myasthenia gravis"},{"number":2047,"drug":"nepafenac","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nepafenac.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nepafenac","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nepafenac_drug\">nepafenac</a>","nsamples":42.0,"avgtftar":0.6047,"avggenetar":90.8372,"moa":"cyclooxygenase inhibitor","indication":"eye inflammation"},{"number":2048,"drug":"neratinib","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/neratinib.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/neratinib","samples":262,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/neratinib_drug\">neratinib</a>","nsamples":262.0,"avgtftar":18.019,"avggenetar":346.4753,"moa":"EGFR inhibitor","indication":"breast cancer"},{"number":2049,"drug":"nesbuvir","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/nesbuvir.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/nesbuvir","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/nesbuvir_drug\">nesbuvir</a>","nsamples":42.0,"avgtftar":1.186,"avggenetar":52.8837,"moa":"RNA polymerase inhibitor","indication":"-"},{"number":2050,"drug":"netupitant","tool":"PANDA-LIONESS","netzoo":"netZooM","netzooRel":"0.4.3","network":"https://granddb.s3.amazonaws.com/drugs/drugNetwork/PANDA/netupitant.csv","ppi":"https://granddb.s3.amazonaws.com/drugs/drugs_ppi.txt","motif":"https://granddb.s3.amazonaws.com/optPANDA/motifs/Hugo_motifCellLine.txt","expression":"https://granddb.s3.amazonaws.com/drugs/drugExpression/Drugs_Gene_Expression_AllSamples.csv","tfs":652,"genes":12328,"ppiLink":"http://string90.embl.de/","refs":"https://pubchem.ncbi.nlm.nih.gov/compound/netupitant","samples":42,"expLink":"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742","nnets":1,"druglink":"<a style=\"text-decoration:none\" href=\"https://grand.networkmedicine.org/drugs/netupitant_drug\">netupitant</a>","nsamples":42.0,"avgtftar":5.8837,"avggenetar":353.186,"moa":"tachykinin antagonist","indication":"nausea|vomiting"}]}